Clinical Trial Update: Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update evaluating dehydroepiandrosterone (DHEA) for women with poor ovarian response undergoing IVF; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diminished Ovarian Reserve
• Infertility

Drugs mentioned

• DHEA (dehydroepiandrosterone)

Snippet

Sponsor: University of Athens | Conditions: Efficacy of DHEA, Pregnancy Rate | Phase 2, Phase 3 | Status: UNKNOWN